2025

A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors
Smouldering disease in paediatric-onset multiple sclerosis
Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions
Physical activity demonstrates protective associations with structural visual metrics in children with multiple sclerosis through time
Vitamin D- should we all take it?
Emphasizing complementary in "Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis"
Identifying axonal injury through the eye: can the cornea provide new clues to axonal injury in MS?
Evaluating Equity, Diversity, Indigeneity, Inclusion, and Accessibility Focused Scholarship in Faculty Promotions in Higher Education Institutions
When does multiple sclerosis start?
Access to therapy for children and adolescents with multiple sclerosis: global considerations in preventing disease progression
Validity of model for predicting risk of relapse in MOGAD
Exploring Treatment Approaches in Pediatric MOG Antibody-Associated Disease: A Survey of Neurologists
The P42 epitope in MOG associated disorders: Understanding regional variations and predictive value
Accelerated Aging in Children With Multiple Sclerosis: Can We Stop the Clock?
Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies
Associations between fronto-limbic white matter connections and internalizing symptoms in pediatric demyelinating disease
Infectious mononucleosis is a more realistic target for preventing multiple sclerosis
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?
Is there truly no progression in NMOSD and MOGAD?
Scoping review of the availability and uptake of disease modifying therapies in children and adolescents with multiple sclerosis
Embodiment of structural racism and multiple sclerosis risk and outcomes in the USA

2024

Neurological involvement in hospitalized children with SARS-CoV-2 infection: a multinational study
A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects
Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing
Brain Volumes in Opsoclonus-Myoclonus Ataxia Syndrome: A Longitudinal Study
Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis
A Systematic Review of Methods and Practice for Integrating Maternal, Fetal, and Child Health Outcomes, and Family Spillover Effects into Cost-Utility Analyses
Depression and anxiety in MS: symptoms or comorbidity?
Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)
The risks and benefits of using AI for diagnosis: beware of unconscious bias
Social network characteristics and their relationships with physical activity in children with multiple sclerosis
Choroid Plexus Volume in Pediatric-Onset Multiple Sclerosis
Compensatory mechanisms amidst demyelinating disorders: insights into cognitive preservation
Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Smouldering-associated worsening or SAW: the next therapeutic challenge in managing multiple sclerosis
The fungal gut microbiota in pediatric-onset multiple sclerosis
Can placebo-controlled phase 2 disease-modifying therapy trials in MS still be justified?
Assessment of dietary intake and its inflammatory potential in persons with pediatric-onset multiple sclerosis
Where does multiple sclerosis come from?
Real-life benefits of high-efficacy therapies for children with multiple sclerosis
OCT-Angiography in AQP4-positive NMOSD: finding subclinical disease using a new tool
Clinical features and outcomes in children with seronegative autoimmune encephalitis
Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein-Antibody-Associated Disease

2023

Family health conditions and parental occupational status modify the relationship between pediatric-onset multiple sclerosis and parental health-related quality of life
Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset
A cross-sectional study of MRI features and the gut microbiome in pediatric-onset multiple sclerosis
Rapid and inexpensive bedside diagnosis of RAN binding protein 2-associated acute necrotizing encephalopathy
Interim guidelines for the assessment and treatment of pain in children with multiple sclerosis
A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effect
Magnetization transfer saturation reveals subclinical optic nerve injury in pediatric-onset multiple sclerosis
Challenges in the Clinical Recognition of Acute Flaccid Myelitis and its Implications
SARS-CoV-2 infection in technology-dependent children: a multicenter case series
Is it ethical to use teriflunomide as an active comparator in phase 3 trials?
Equity, diversity and inclusion in academic publishing: Can we move the needle?
Emboldened or not: The potential fall-out of a failed anti-EBV trial in multiple sclerosis
Inequality in accessing healthcare for people with MS
Is multiple sclerosis a glymphaticopathy?
Social network size and mental health outcomes in youth with neuroinflammatory disorders
Can we improve outcomes in MS around the world? Access and global considerations across income strata
Pediatric Multiple Sclerosis: Changing the Trajectory of Progression
Sleep, physical activity, and psychological outcomes in children and adolescents with pediatric onset multiple sclerosis
Beyond the B-cell as a treatment target in multiple sclerosis
Deviation From Normative Whole Brain and Deep Gray Matter Growth in Children With MOGAD, MS, and Monophasic Seronegative Demyelination
Delayed oculomotor response associates with optic neuritis in youth with demyelinating disorders
Multiple types of relapses in MOG antibody disease
Are we ready for CD19-targeted CAR T-cell therapies in MS?

2022

Physical Activity and Sedentary Behavior Patterns Across Weekdays and Weekend Days in Youth With Multiple Sclerosis and Controls
Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study
Feasibility of a theory-informed mobile app for changing physical activity in youth with multiple sclerosis
Multiple sclerosis is one disease
The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents
Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
Infection-Related Myelopathies
Outcomes in influenza and RANBP2 mutation-associated acute necrotizing encephalopathy of childhood
The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome
Pandemic-associated mental health changes in youth with neuroinflammatory disorders
Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases
Is EBV the cause of multiple sclerosis?
Disrupted cognitive development following pediatric acquired demyelinating syndromes: a longitudinal study
Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome
Progressive retinal changes in pediatric multiple sclerosis
Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders
What are T-cells telling us about how EBV causes MS?
Linking X to MS: Immunity and demyelination on the X-chromosome in MS
High efficacy treatment is not enough in MS: Socioeconomic factors are key to improving outcomes
Implications of Low-Titer MOG Antibodies
Editorial: New Therapeutic Options for Rare Diseases
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective
Structural visual metrics associate with moderate to vigorous physical activity in youth with pediatric onset neuroinflammatory disorders

2021

Examining cognitive speed and accuracy dysfunction in youth and young adults with pediatric-onset multiple sclerosis using a computerized neurocognitive battery
Acute flaccid myelitis: long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitis
Impact of COVID-19 public health measures on myelin oligodendrocyte glycoprotein IgG-associated disorders in children
APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies
The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
Silent New Brain MRI Lesions in Children with MOG-Antibody Associated Disease
It is time to move to alternative clinical trial designs: Reconsidering the holy grail of trial methodology
Real-world outcomes in pediatric MS: Psychiatric comorbidities and school performance
Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating Syndromes
COVID-19 vaccines and multiple sclerosis disease-modifying therapies
Pro-inflammatory adiponectin in pediatric-onset multiple sclerosis
Acute flaccid myelitis: cause, diagnosis, and management
Infection-Related Myelopathies
It is time to move to alternative clinical trial designs: Reconsidering the holy grail of trial methodology
Lifestyle factors and outcomes in paediatric-onset multiple sclerosis
Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis
Physical Activity in Youth with Multiple Sclerosis receiving the ATOMIC intervention: Social connectedness above all else

2018

Incidence and prevalence of MS in children: A population-based study in Ontario, Canada.
Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes.
Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.
Radiologically isolated syndrome in children: Current knowledge and future directions.
Neuroimmune disorders of the central nervous system in children in the molecular era.
Acute Flaccid Paralysis and Enteroviral Infections.
Adherence in Youth With Multiple Sclerosis: A Qualitative Assessment of Habit Formation, Barriers, and Facilitators.
Evaluation of an Ophthalmoscopy Simulator to Teach Funduscopy Skills to Pediatric Residents.
Detection and clinical correlation of leukocortical lesions in pediatric-onset multiple sclerosis on multi-contrast MRI.
Lyme disease presenting with multiple cranial neuropathies on MRI.
Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.
MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.
Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis.
Specific myelopathy diagnoses using advancing diagnostics
Involvement of the Amygdala in Memory and Psychosocial Functioning in Pediatric-Onset Multiple Sclerosis.
Icon of a book